Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ExpressTec is a biopharmaceutical company specializing in high-yield, plant-based recombinant protein production. Utilizing its proprietary rice-based expression system, the company manufactures proteins, enzymes, and vaccines that are animal-free and cost-effective. The technology, originally developed by Ventria Bioscience, enables the production of complex proteins like lactoferrin and lysozyme for use in human health, nutrition, and cell culture media. ExpressTec operates a cGMP-compliant manufacturing facility in Kansas and provides contract manufacturing services to the broader biotech industry. The company's platform offers significant advantages in scalability and safety compared to traditional mammalian or microbial expression systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ExpressTec.